Edgewise Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 02/17/2026 | 15.52 M | $385.09 M | 0.00% | 14.71% |
| RA CAPITAL MANAGEMENT, L.P. | 02/17/2026 | 10.43 M | $258.78 M | 0.00% | 9.89% |
| BLACKROCK, INC. | 02/12/2026 | 6.63 M | $164.54 M | 4.39% | 6.29% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 6.58 M | $163.18 M | -9.99% | 6.23% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 6.54 M | $162.32 M | 6.01% | 6.20% |
| NOVO HOLDINGS A/S | 02/17/2026 | 5.35 M | $132.76 M | 0.00% | 5.07% |
| BRAIDWELL LP | 02/17/2026 | 5.21 M | $129.31 M | 0.00% | 4.94% |
| VANGUARD GROUP INC | 01/29/2026 | 4.87 M | $120.89 M | 1.41% | 4.62% |
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 4.57 M | $113.33 M | -8.28% | 4.33% |
| SIREN, L.L.C. | 02/13/2026 | 4.53 M | $112.41 M | 16.24% | 4.29% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 4.46 M | $110.62 M | 17.44% | 4.23% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 4.19 M | $104.00 M | 88.09% | 3.97% |
| CORMORANT ASSET MANAGEMENT, LP | 02/17/2026 | 3.29 M | $81.52 M | -18.08% | 3.11% |
| MORGAN STANLEY | 02/13/2026 | 2.91 M | $72.23 M | 234.71% | 2.76% |
| UBS GROUP AG | 01/29/2026 | 2.12 M | $52.54 M | 1,755.00% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.75 M | $43.34 M | 1.66% | 1.66% |
| STATE STREET CORP | 02/13/2026 | 1.72 M | $42.62 M | 1.03% | 1.63% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.66 M | $41.08 M | -3.81% | 1.57% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/17/2026 | 1.57 M | $39.05 M | 11.22% | 1.49% |
| BELLEVUE GROUP AG | 02/17/2026 | 1.53 M | $37.93 M | -44.94% | 1.45% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/17/2026 | 1.50 M | $37.22 M | 0.00% | 1.42% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.47 M | $36.60 M | 359.25% | 1.40% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.21 M | $30.11 M | 2.58% | 1.15% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.19 M | $29.44 M | 8.31% | 1.12% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.04 M | $25.71 M | 1,241.15% | 0.98% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 910.00 K | $22.58 M | 100.00% | 0.86% |
| ABRDN PLC | 01/16/2026 | 821.94 K | $20.40 M | 32.60% | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/17/2026 | 765.69 K | $19.00 M | 0.00% | 0.73% |
| NORGES BANK | 02/10/2026 | 751.36 K | $18.64 M | 100.00% | 0.71% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 746.56 K | $18.53 M | 49.72% | 0.71% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 718.37 K | $17.83 M | 36.10% | 0.68% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/17/2026 | 704.08 K | $17.47 M | -1.96% | 0.67% |
| FMR LLC | 02/17/2026 | 692.96 K | $17.20 M | 173.54% | 0.66% |
| MARSHALL WACE, LLP | 02/13/2026 | 681.92 K | $16.93 M | 100.00% | 0.65% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 640.40 K | $15.89 M | 100.00% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 611.38 K | $15.17 M | 2.31% | 0.58% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 568.31 K | $14.10 M | 0.00% | 0.54% |
| NORTHERN TRUST CORP | 02/17/2026 | 559.65 K | $13.89 M | -4.80% | 0.53% |
| CANDRIAM S.C.A. | 04/30/2026 | 501.21 K | $12.44 M | 126.63% | 0.48% |
| OPALEYE MANAGEMENT INC. | 04/13/2026 | 500.00 K | $12.41 M | 0.00% | 0.47% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 437.82 K | $10.86 M | -15.84% | 0.42% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 427.69 K | $10.61 M | -22.26% | 0.41% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 394.70 K | $9.79 M | -41.75% | 0.37% |
| BARCLAYS PLC | 02/13/2026 | 372.74 K | $9.25 M | 58.85% | 0.35% |
| STEMPOINT CAPITAL LP | 02/17/2026 | 360.88 K | $8.96 M | 100.00% | 0.34% |
| 02/17/2026 | 350.00 K | $8.69 M | 100.00% | 0.33% | |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 337.34 K | $8.37 M | -32.83% | 0.32% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 296.21 K | $7.35 M | -46.70% | 0.28% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 271.39 K | $6.73 M | 104.81% | 0.26% |
| ALLY BRIDGE GROUP (NY) LLC | 02/17/2026 | 250.00 K | $6.20 M | 100.00% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edgewise Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 241 institutional investors and hedge funds held shares of Edgewise Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 1.31 M
DIMENSIONAL FUND ADVISORS LP: 1.22 M
abrdn plc: 826,059
VANGUARD FIDUCIARY TRUST CO: 521,726
Candriam S.C.A.: 447,416
Nuveen, LLC: 335,783
115.48% of Edgewise Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 129.19 M shares in the last 24 months. This purchase volume represents approximately $3.70 B in transactions.